Bliss GVS Pharma Authorizes KMPs for Materiality Disclosure

Bliss GVS Pharma Ltd has officially authorized its Key Managerial Personnel (KMPs) to determine the materiality of events and information and to make necessary disclosures to the stock exchanges. This authorization is in compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015. The authorized KMPs include Mr. Narsimha Shibroor Kamath (Managing Director), Mr. Rahul Adakmol (Chief Executive Officer), and Mr. Deepak Sawant (Chief Financial Officer) for determining materiality. Ms. Aditi Bhatt (Company Secretary) is authorized for making the disclosures. Contact details for these individuals are provided for official communication.